BIO-TECHNE Corp (TECH) Risk Factors

Recent key developments

Concrete developments — dated events, named agreements and instruments, legal proceedings — that BIO-TECHNE Corp surfaced in its latest filing.

• Acquired Lunaphore at the beginning of fiscal 2024.2024
• Invested in Spear Bio at the beginning of fiscal 2025.2025
• Obtained a 19.9% ownership stake in Wilson Wolf, with an obligation to acquire the remaining ownership by end of calendar 2027.2027
• Entered into a Merger Agreement on June 25, 2026, where each share of common stock will be converted into the right to receive $73.00 in cash, subject to regulatory and shareholder approvals.June 25, 2026
• The company would be required to pay a termination fee of approximately $230.5 million if the Merger Agreement is terminated under specified circumstances.
• The Credit Agreement provides for a $1 billion revolving credit facility, and as of August 17, 2026, the company had drawn $200 million under the agreement.August 17, 2026
• Beginning in early April 2025, the U.S. implemented tariffs on imports from a wide range of countries, prompting retaliatory tariffs; significant tariffs between the U.S. and China remain in effect.April 2025
• Russia's military invasion of Ukraine and responses by US and European countries have caused political, humanitarian and economic crises.
• Several states, including California, Virginia, Utah, Colorado, and Connecticut, have passed broad privacy legislation.